PMC3563344_01
Timeline of treatment.
opth-7-229Fig1.jpg
PMC3563344_01_opth-7-229Fig1.jpg
f1-opth-7-229
The patient was slow to respond, but showed resolution of the epithelial defect over a 3-week period with significant corneal toxicity secondary to the trifluridine in the form of conjunctival hyperaemia and punctate epitheliopathy (Figure 1).